McDermott Will & Emery AARPI

Corporate Advisory

David Revcolevschi focuses his practice on French and international securities offerings, mergers and acquisitions, and more generally on the securities and corporate law and corporate governance issues faced by publicly listed companies.

David has extensive experience in equity and equity-linked securities offerings, representing issuers, underwriters, and shareholders. He has notably advised on more than 35 IPO projects on Euronext Paris, Nasdaq, the Hong Kong Stock Exchange and the London Stock Exchange and numerous other securities issuances by companies operating in the life science (biotechnology, medical device), technology (software, hardware, telecom), airlines, aerospace, real estate, leisure and entertainment, chemicals, utilities and financial sectors.

David also advises publicly listed and private companies on acquisitions, dispositions, mergers and joint ventures in a wide range of industries and his experience includes cross-border transactions involving companies and shareholders across Europe and the United States, as well as China and the Middle East and North Africa.

In addition, David also represents issuers, directors, officers and employees in enforcement actions by the French securities regulator (AMF).

Read full biography: https://www.mwe.com/people/david-revcolevschi/